BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32616496)

  • 1. External Validation of the International IgA Nephropathy Prediction Tool.
    Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients.
    Zhang Q; Zhang Q; Duan Z; Chen P; Chen JJ; Li MX; Zhang JJ; Huo YH; Zhang WX; Yang C; Zhang Y; Chen X; Cai G
    Clin Interv Aging; 2024; 19():911-922. PubMed ID: 38799377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of the International Prognosis Prediction Model of IgA Nephropathy.
    Hu L; Fang Y; Huang J; Liu J; Xu L; He W
    Ren Fail; 2024 Dec; 46(1):2313174. PubMed ID: 38345077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort.
    Ying D; Lu M; Zhi Y; Shi P; Cao L; Wang Q; Zhang Y; Zhang J
    Clin Exp Nephrol; 2024 Jan; 28(1):59-66. PubMed ID: 37713045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
    Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Katafuchi R; Er L; Espino-Hernandez G; Kim SJ; Reich HN; Feehally J; Cattran DC;
    JAMA Intern Med; 2019 Jul; 179(7):942-952. PubMed ID: 30980653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
    Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients.
    Bagchi S; Upadhyay AD; Barwad A; Singh G; Subbiah A; Yadav RK; Mahajan S; Bhowmik D; Agarwal SK
    Kidney Int Rep; 2022 Jun; 7(6):1210-1218. PubMed ID: 35685319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
    Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Er L; Reich HN; Barratt J; Cattran DC;
    Kidney Int; 2022 Jul; 102(1):160-172. PubMed ID: 35490842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
    Bon G; Jullien P; Masson I; Sauron C; Dinic M; Claisse G; Pelaez A; Thibaudin D; Mohey H; Alamartine E; Mariat C; Maillard N
    Nephrol Dial Transplant; 2023 Sep; 38(10):2257-2265. PubMed ID: 37316441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy.
    Joo YS; Kim HW; Baek CH; Park JT; Lee H; Lim BJ; Yoo TH; Moon KC; Chin HJ; Kang SW; Han SH
    Kidney Res Clin Pract; 2022 Sep; 41(5):556-566. PubMed ID: 35545218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
    Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
    Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy.
    Hwang D; Choi K; Cho NJ; Park S; Yu BC; Gil HW; Lee EY; Choi SJ; Park MY; Kim JK; Hwang SD; Kwon SH; Jeon JS; Noh H; Han DC; Kim H
    Nephrology (Carlton); 2021 Jul; 26(7):594-602. PubMed ID: 33624915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
    Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy.
    Ouyang Y; Zhao Z; Li G; Luo H; Xu F; Shao L; Chen Z; Yu S; Jin Y; Xu J; Shi M; Hussain HMJ; Du W; Fang Z; Pan X; Wang W; Xie J; Chen N
    Front Immunol; 2021; 12():753901. PubMed ID: 34721428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.